Pharmarack Technologies Profile
Key Indicators
- Authorised Capital ₹ 1.10 M
as on 16-11-2024
- Paid Up Capital ₹ 0.51 M
as on 16-11-2024
- Company Age 9 Year, 2 Months
- Last Filing with ROC 31 Mar 2023
- Revenue 109.58%
(FY 2023)
- Profit -159.22%
(FY 2023)
- Ebitda -159.26%
(FY 2023)
- Net Worth -185.90%
(FY 2023)
- Total Assets 57.93%
(FY 2023)
About Pharmarack Technologies
The Company is engaged in the Healthcare Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 1.10 M and a paid-up capital of Rs 0.51 M, as per Ministry of Corporate Affairs (MCA) records.
Rakeshchandra Sinha, Dhruv Gulati, Mukund Thakkar, and Two other members serve as directors at the Company.
- CIN/LLPIN
U72900PN2015PTC156535
- Company No.
156535
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
21 Sep 2015
- Date of AGM
29 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Pune
Industry
Company Details
- Location
Pune, Maharashtra, India
- Telephone
- Email Address
- Website
- Social Media
- Apps
Who are the key members and board of directors at Pharmarack Technologies?
Board Members(5)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Rakeshchandra Sinha  | Director | 26-Aug-2021 | Current |
| Mukund Thakkar | Director | 26-Aug-2021 | Current |
| Dhruv Gulati | Director | 22-Feb-2024 | Current |
| Saurabh Mashruwala | Director | 26-Aug-2021 | Current |
Kalyanasundaram Subramanian  | Director | 05-Apr-2021 | Current |
Financial Performance and Corporate Structure Insights of Pharmarack Technologies.
Pharmarack Technologies Private Limited, for the financial year ended 2023, experienced significant growth in revenue, with a 109.58% increase. The company also saw a substantial fall in profitability, with a 159.22% decrease in profit. The company's net worth observed a substantial decline by a decrease of 185.9%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Pharmarack Technologies?
In 2022, Pharmarack Technologies had a promoter holding of 93.67% and a public holding of 6.33%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Sun Pharma Laboratories LimitedActive 27 years 11 monthsRakeshchandra Sinha and Kalyanasundaram Subramanian are mutual person
Sun Pharma Distributors LimitedActive 5 years 9 monthsRakeshchandra Sinha and Kalyanasundaram Subramanian are mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Pharmarack Technologies?
Pharmarack Technologies has a workforce of 557 employees as of Apr 06, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Pharmarack Technologies, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Pharmarack Technologies's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
